# Inclisiran: UK patient leaflet, explained

Source: patient information leaflet for Leqvio 284 mg Solution For Injection In Prefilled Syringe (licence PLPI163781372), approved by the MHRA. Leaflet dated 2026-01-23. Checked against the source on 2026-11-19.

Original leaflet: https://mhraproducts4853.blob.core.windows.net/docs/ccaf35329fda7a6de0b0b56b5eaad9e77d8d8228

Canonical page: https://pestle.health/uk/inclisiran

## What is inclisiran for?
Leqvio is an injection containing inclisiran, which lowers LDL-cholesterol ("bad" cholesterol). It is used alongside a cholesterol-lowering diet in adults with a high blood cholesterol level (primary hypercholesterolaemia, including heterozygous familial and non-familial, or mixed dyslipidaemia).

## Key facts
- Leqvio lowers LDL-cholesterol by limiting the production of a protein called PCSK9.
- It is given as an injection under the skin by a doctor, pharmacist or nurse: one dose, a second dose after 3 months, then a dose every 6 months.
- You should stay on your cholesterol-lowering diet and keep taking your statin all the time you receive Leqvio.
- It must not be given to children and adolescents under 18 years of age.
- If you miss your appointment, contact your doctor, pharmacist or nurse as soon as you can to arrange your next injection.

## Who should not take inclisiran?
- If you are allergic to inclisiran or any of the other ingredients of this medicine

## Check with a doctor or pharmacist first if
- If you are receiving dialysis
- If you have severe liver disease
- If you have severe kidney disease
- Do not give to children and adolescents under 18 years of age, because there is no experience of using it in this age group

## Side effects that need urgent help


## How common are the side effects?
### Common (Up to 1 in 10 people)
- Injection site reactions, such as pain, redness or rash

## Other medicines the leaflet mentions
- Any other medicines you are using, have recently used or might use

## Pregnancy and breastfeeding
The use of Leqvio should be avoided during pregnancy. It is not known whether Leqvio passes into breast milk, so ask your doctor, pharmacist or nurse for advice before you are given it if you are pregnant, breast-feeding, think you may be pregnant or are planning a baby.

## How to take it
- The recommended dose is 284 mg given by injection under the skin (subcutaneous injection).
- The next dose is given after 3 months, followed by further doses every 6 months.
- It is given by a doctor, pharmacist or nurse into the abdomen; the upper arm or thigh may also be used.
- Stay on your cholesterol-lowering diet and keep taking your statin while you receive Leqvio.
- If you miss your appointment, contact your doctor, pharmacist or nurse as soon as you can to arrange your next injection.

---
Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets.
